• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trial Listings
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Market Research
    • Benchmark Reports
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Clinical Trial Listings
  • Advertise
  • COVID-19
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » SCRS Launches Collaboration to Alleviate Site Financial Burdens

SCRS Launches Collaboration to Alleviate Site Financial Burdens

March 20, 2023

The Society for Clinical Research Sites (SCRS) has kicked off the Site Payment Initiative, an endeavor that will bring sites, sponsors and CROs together to tackle financial struggles sites frequently name as pain points.

Initially, the program intends to address multiple financial challenges encountered by sites during trials, including holdback payments, delayed payment frequencies and taxes on patient stipends, among others. The initiative looks to ensure that sites receive 100 percent of earned revenue, see monthly payments instead of quarterly payments, and enable participants to receive allowances untaxed.

“Many of these payment and financial challenges have unfortunately burdened sites for decades,” Allyson Small, SCRS’ chief operating officer, said. “A unified voice to advocate for the financial needs of sites and patients is still very much needed, and we are confident that now is the time to enact change. By working with this group of motivated sites and industry partners, we hope to enhance sustainable practices that benefit clinical research as a whole.”

Stakeholders interested in taking part in the program should contact SCRS at info@myscrs.org.

 

To view more CenterWatch Weekly stories, click here.

Upcoming Events

  • 06Jun

    Gene & Cell Therapy Regulation: Comparability and Other New Developments

  • 07Jun

    Developing World-Class SOPs: Optimizing Quality and Compliance

  • 08Jun

    Implementing ICH E8 R1 Recommendations Increases Site and Participant Relationship Scoring Measures

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • MAGI East 2023

    MAGI East 2023 Preview: Janssen Reports on Environmental Impact of Trials

  • Complexity-360x240.png

    Phase 3 Trials Significantly Rising in Complexity, Says CSDD

  • Quality Level Scale

    Build Quality into Trials Like You’d Build a House, Says FDA’s BIMO Director

  • DE&I

    Trust-Building, Community Connection Still Essential to DE&I Efforts, Experts Say

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 703.538.7600 – Toll free 888.838.5578

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing